eISSN: 1896-9151
ISSN: 1734-1922
Archives of Medical Science
Current issue Archive Manuscripts accepted About the journal Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
3/2008
vol. 4
 
Share:
Share:
more
 
 
abstract:

Clinical research
Ropivacaine plasma concentrations after thoracic epidural anaesthesia

Georgia Kostopanagiotou
,
Paraskevi Matsota
,
Chrysanthi Batistaki
,
Zoi Souliotis
,
Ageliki Pandazi
,
Sophia Markantonis

Arch Med Sci 2008; 4, 3: 300–304
Online publish date: 2008/10/15
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 

Introduction: The pharmacokinetic profile of ropivacaine varies according to the site of administration. The aim of this study was to determine ropivacaine plasma concentrations after thoracic epidural administration in patients undergoing abdominal surgery under combined epidural – general anaesthesia.
Material and methods: The study included 15 patients, aged 45-77 years, ASA I and II, scheduled for abdominal procedures, under combined epidural-general anaesthesia. Epidural was performed at T10-T11 or T11-T12 interspaces and all patients received 5 ml of ropivacaine 0.75% with fentanyl 100 µg. Blood samples were collected at 10, 40, 70, 100 and 130 min following ropivacaine administration. Determination of blood levels was achieved with high performance liquid chromatography.
Results: Mean ropivacaine plasma concentrations determined at 10, 40, 70, 100 and 130 min after epidural administration showed significant intersubject variation and were found to be 0.66±0.48, 0.43±0.26, 0.47±0.34, 0.40±0.2, 0.33±0.19 µg/ml, respectively. Peak plasma concentrations occurred 10 min after administration in 10 patients, at 40 min in one patient, at 70 min in 3 patients and at 100 min in 1 patient with a mean of 0.65±0.46 µg/ml (range 0.25-1.59 µg/ml). The terminal half-life determined in 12 of the 15 patients was roughly estimated to be between 60 and 245 min (mean ± SD = 122±55 min).
Conclusions: Thoracic epidural administration of 5 ml ropivacaine 0.75% achieved plasma concentrations of between 0.1-1.59 µg/ml with an elimination half-life of approximately 122±55 min.
keywords:

ropivacaine, plasma levels, thoracic epidural

FEATURED PRODUCTS
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe